Standalone Results Q2FY17: (Rs. in crore)
|Reported Results||YoY (%)|
|EBITDA Margin||16.7%||39 bps|
|Net Profit (adjusted)||20||25|
Aarti Drugs Ltd is currently trading at Rs. 649.2, up by 2.1 points or 0.32% from its previous closing of Rs. 647.1 on the BSE.
The scrip opened at Rs. 655 and has touched a high and low of Rs. 659 and Rs. 645.1 respectively. So far 67445(NSE+BSE) shares were traded on the counter. The stock is currently trading below its 50 DMA.